2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Cardiovascular disease is the leading cause of death in women and men globally, with most
due to atherosclerotic cardiovascular disease (ASCVD). Despite progress during the last 30 …

Despite significant advancements in critical care medicine, limited attention has been given
to sex and gender disparities in management and outcomes of patients admitted to the …

Clinical medicine requires the integration of various forms of patient data including
demographics, symptom characteristics, electrocardiogram findings, laboratory values …

Recent years have witnessed significant transformations in cardiovascular medicine, driven
by the rapid evolution of artificial intelligence (AI). This sco** review was conducted to …

Abstract Background The Triglyceride-glucose (TyG) index, as a surrogate marker of insulin
resistance, is independently associated with the severity of coronary artery lesions and the …

BACKGROUND: The effect of myocardial infarction (MI) on life expectancy is difficult to study
because the prevalence of MI hinders direct comparison with the life expectancy of the …

Aims The heart rejuvenating effects of circulating growth differentiation factor 11 (GDF11), a
transforming growth factor-β superfamily member that shares 90% homology with myostatin …

Abstract Background and Aims Cardiogenic shock (CS) remains the primary cause of in-
hospital death after acute coronary syndromes (ACS), with its plateauing mortality rates …

Abstract Background and Aims Circulating proenkephalin (PENK) is a stable endogenous
polypeptide with fast response to glomerular dysfunction and tubular damage. This study …